Seroprevalence of hepatitis B and C and human immunodeficiency virus infections and high-risk practices in the Bobo-Dioulasso prison and correctional facility, Burkina Faso

Abstract

Introduction. The aim of this study was to determine the seroprevalence of hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) infections and risky practices at the Bobo-Dioulasso remand prison (MACB).
Methods. From August to December 2017, a descriptive cross-sectional study was conducted in the Bobo-Dioulasso remand prison. Following an information session on HBV, HCV and HIV infection, the inmates present were offered a survey. Consecutive recruitment of consenting inmates aged 18 years or older, regardless of sex, was performed. Approximately 7 mL of whole blood was collected from each inmate, processed and used to test for HBsAg, anti-HCV and anti-HIV infection markers using ELISA kits. Data were collected using a structured questionnaire.
Results. Of the 125 prisoners interviewed, 92.8% were men. The mean age was 35 years (± 11 years). The prevalence of HBV, HCV and HIV infection was 9.6%, 5.6% and 3.2% respectively. The main risk practices reported were sharing of sharp instruments (22.6%), including 24% razors and 18.4% blades, and unprotected sex (41%). The majority of HBV-infected prisoners did not systematically use condoms and had multiple sexual partners.
Conclusion. The prevalence of viral hepatitis B and C and human immunodeficiency virus infection is high among prisoners. Prison-based interventions are essential